Author

Hans-Peter Huber

Observed names: H Huber, H. Huber

Institution: Fritz Bender Stiftung

Observed institutions: University of Vienna, Vienna General Hospital, Fritz Bender Stiftung, Medical University of Vienna

ORCID: 0009-0004-0164-5828

Observed ORCID: 0009-0004-0164-5828

OpenAlex ID: A5113463754

The impact of hemoglobin levels on fatigue and quality of life in cancer patients

2002 · B. Holzner, G. Kemmler, et al. · Annals of Oncology · 172

European School of Oncology First Euro-American Forum on Lung Cancer Treatment

1994 · P.A. Bunn, N. Van Zandwijk, et al. · European Journal of Cancer · 20

Personalized Cancer Care Conference

2013 · Kurt Zänker, Enrico Mihich, et al. · Journal of Personalized Medicine · 4

[Tumor markers in bronchus cancer].

1989 · R W Gasser, H Denz, et al. · PubMed · 4

Cellular Drug Resistance in Lung Cancer

2009 · G. Krajnik, H. Huber, et al. · Onkologie · 3

[Is there progress in chemotherapy for breast cancer?].

2001 · C Wenzel, M Schmidinger, et al. · PubMed · 3

Personalized Cancer Care: Risk Prediction, Early Diagnosis, Progression, and Therapy

2016 · Kurt S. Zänker, Anne-Lise Borresen-Dale, et al. · Biomedicine Hub · 2

[Bronchial cancer--development, diagnosis, therapy, prognosis].

1994 · S Zöchbauer, G Krajnik, et al. · PubMed · 2

Comments on Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group, van Zandwijk et al., Eur J Cancer 1997, 33, 1759-1766.

1998 · C Prior, J Thaler, et al. · PubMed · 1

Briefe an die Herausgeber – Letters to the Editors

2009 · E. Röttinger, R.M. Mader, et al. · Onkologie

Informationen für die Klinik

2009 · H. Löffler, H. König, et al. · Onkologie

Hinweise für Autoren – Instructions to Authors

2009 · H. Löffler, H. König, et al. · Onkologie

Inhalt, Vol. 9, No. 2, 1986

2009 · E. Dühmke, H.H. Fülle, et al. · Onkologie

Neuigkeiten für die klinische Praxis

2009 · E. Dühmke, H.H. Fülle, et al. · Onkologie

2009 · E. Dühmke, H.H. Fülle, et al. · Onkologie

In memoriam Mildred Scheel

2009 · H.K. Mahmoud, U.W. Schaefer, et al. · Onkologie

Neuigkeiten für die klinische Praxis

2009 · H.K. Mahmoud, U.W. Schaefer, et al. · Onkologie

Onkologie-Mitteilungen

2009 · H.K. Mahmoud, U.W. Schaefer, et al. · Onkologie

Hinweise für Autoren

2009 · H.K. Mahmoud, U.W. Schaefer, et al. · Onkologie

2009 · H.K. Mahmoud, U.W. Schaefer, et al. · Onkologie

Fatigue and quality of life (QoL) in cancer patients — relations between haematological parameters and subjective assessment

1999 · B. Holzner, M. Koop, et al. · European Journal of Cancer

170 P Phase II trial of lnterferon-γ (LFN-γ)/interleukln-2 (1L-2) for advanced renal cell carcinoma (RCC)

1996 · M.P. Djavanmard, G.G. Steger, et al. · European Journal of Cancer

[Lung cancer: present concepts of treatment].

1980 · H Huber, G M Salzer, et al. · PubMed

[Combined treatment modalities in bronchial carcinoma].

1978 · H Huber, K Rieche · PubMed

Works count: 24

Citation count: 211

H-index: 4

I10-index: 2